<![CDATA[Embla Medical — April 2025]]>Jeg blev endnu mere langsigtet på denne melding: Embla rundbarberes af Danske Bank - sænker anbefaling og kursmål https://proinvestor.com/investornyt/1300702/embla-rundbarberes-af-danske-bank-saenker-anbefaling-og-kursmal

]]>https://dev.proinvestor.com/forum/topic/401344/embla-medical-april-2025RSS for NodeSat, 06 Jun 2026 05:03:54 GMTTue, 08 Apr 2025 08:06:36 GMT60<![CDATA[Reply to Embla Medical — April 2025 on Wed, 30 Apr 2025 09:02:17 GMT]]>Embla leverer solidt uden effekt fra tilskudsordning https://proinvestor.com/investornyt/1310113/embla-leverer-solidt-uden-effekt-fra-tilskudsordning

]]>https://dev.proinvestor.com/forum/post/8056411https://dev.proinvestor.com/forum/post/8056411Wed, 30 Apr 2025 09:02:17 GMT<![CDATA[Reply to Embla Medical — April 2025 on Tue, 29 Apr 2025 03:40:44 GMT]]>Embla Medical rammer lidt under forventning i første kvartal - effekt af toldkrig udestår https://proinvestor.com/investornyt/1309397/embla-medical-rammer-lidt-under-forventning-i-forste-kvartal-effekt-af-toldkrig-udestar

]]>https://dev.proinvestor.com/forum/post/8056415https://dev.proinvestor.com/forum/post/8056415Tue, 29 Apr 2025 03:40:44 GMT<![CDATA[Reply to Embla Medical — April 2025 on Tue, 29 Apr 2025 03:14:19 GMT]]>Rapport: https://news.cision.com/embla-medical-hf-/r/embla-medical-hf--interim-report-q1-2025,c4142115

]]>https://dev.proinvestor.com/forum/post/8056414https://dev.proinvestor.com/forum/post/8056414Tue, 29 Apr 2025 03:14:19 GMT<![CDATA[Reply to Embla Medical — April 2025 on Tue, 29 Apr 2025 03:13:37 GMT]]>2025 Outlook

Organic sales growth guidance is unchanged at 5-8%.*
EBITDA margin before special items guidance is unchanged at 20-21%.*

]]>https://dev.proinvestor.com/forum/post/8056412https://dev.proinvestor.com/forum/post/8056412Tue, 29 Apr 2025 03:13:37 GMT<![CDATA[Reply to Embla Medical — April 2025 on Tue, 29 Apr 2025 03:12:49 GMT]]>IBD/EBITDA was 2.5x at the end of Q1 2025, which is within our target range of 2-3x EBITDA. In line with our capital structure and capital allocation policy a share buyback program was reinitiated in early February. During Q1 2025, Embla Medical bought back 295,653 shares at a market value of approximately USD 1.3 million.

]]>https://dev.proinvestor.com/forum/post/8056407https://dev.proinvestor.com/forum/post/8056407Tue, 29 Apr 2025 03:12:49 GMT<![CDATA[Reply to Embla Medical — April 2025 on Tue, 29 Apr 2025 03:12:32 GMT]]>Net profit grew by 45% and was USD 12 million with a net profit margin of 6%, compared to 4% in Q1 2024.
Free cash flow amounted to USD 8 million or 4% of sales, compared to negative free cash flow of USD 7 million or negative 4% of sales in Q1 2024. Free cash flow was solid, benefiting from strong operating results, but it should be noted that cash flow is seasonally low in the first quarter of the year.

]]>https://dev.proinvestor.com/forum/post/8056413https://dev.proinvestor.com/forum/post/8056413Tue, 29 Apr 2025 03:12:32 GMT<![CDATA[Reply to Embla Medical — April 2025 on Tue, 29 Apr 2025 03:12:17 GMT]]>in Q1 2024 and continued cost control in SG&A.

]]>https://dev.proinvestor.com/forum/post/8056410https://dev.proinvestor.com/forum/post/8056410Tue, 29 Apr 2025 03:12:17 GMT<![CDATA[Reply to Embla Medical — April 2025 on Tue, 29 Apr 2025 03:11:45 GMT]]>Highlights Q1 2025

Sales amounted to USD 203 million and organic growth was 4%, compared to 7% in Q1 2024.
Prosthetics & Neuro Orthotics sales grew by 9% organic, while our Bracing & Supports and Patient Care sales ended flat in the first quarter of 2025, compared to 10%, 1% and 6% respectively in Q1 2024.
Gross profit margin was 63%, compared to 62% before special items in Q1 2024 (60% reported). The increase is supported by the manufacturing cost reduction initiatives implemented

]]>https://dev.proinvestor.com/forum/post/8056408https://dev.proinvestor.com/forum/post/8056408Tue, 29 Apr 2025 03:11:45 GMT<![CDATA[Reply to Embla Medical — April 2025 on Fri, 11 Apr 2025 11:18:22 GMT]]>Embla får skåret kursmålet til 34,50 kr. fra 40 kr. hos Carnegie https://proinvestor.com/investornyt/1302275/embla-far-skaret-kursmalet-til-3450-kr-fra-40-kr-hos-carnegie

]]>https://dev.proinvestor.com/forum/post/8056406https://dev.proinvestor.com/forum/post/8056406Fri, 11 Apr 2025 11:18:22 GMT<![CDATA[Reply to Embla Medical — April 2025 on Thu, 10 Apr 2025 06:31:40 GMT]]>Embla Medical indledes med "køb" hos norsk børshus https://proinvestor.com/investornyt/1301653/embla-medical-indledes-med-kob-hos-norsk-borshus

]]>https://dev.proinvestor.com/forum/post/8056409https://dev.proinvestor.com/forum/post/8056409Thu, 10 Apr 2025 06:31:40 GMT